Vascular Dysfunction in a Transgenic Model of Alzheimer's Disease: Effects of CB1R and CB2R Cannabinoid Agonists.

about

Vascular Dysfunction in a Transgenic Model of Alzheimer's Disease: Effects of CB1R and CB2R Cannabinoid Agonists.

Item

http://www.wikidata.org/entity/Q41105693

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Vascular Dysfunction in a Tran ...... and CB2R Cannabinoid Agonists.

@en

type

Item

label

Vascular Dysfunction in a Tran ...... and CB2R Cannabinoid Agonists.

@en

prefLabel

Vascular Dysfunction in a Tran ...... and CB2R Cannabinoid Agonists.

@en

P1476

Vascular Dysfunction in a Tran ...... and CB2R Cannabinoid Agonists.

@en

P2093

Ana M Martín-Moreno

http://www.w3.org/2001/XMLSchema#string

Begoña Brera

http://www.w3.org/2001/XMLSchema#string

Jorge Navarro-Dorado

http://www.w3.org/2001/XMLSchema#string

Nuria Villalba

http://www.w3.org/2001/XMLSchema#string

Teresa Tejerina

http://www.w3.org/2001/XMLSchema#string

P2860

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities

Why do cannabinoid receptors have more than one endogenous ligand?

Vascular targets for cannabinoids: animal and human studies

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

Cannabinoids control spasticity and tremor in a multiple sclerosis model

Cannabinoids protect astrocytes from ceramide-induced apoptosis through the phosphatidylinositol 3-kinase/protein kinase B pathway

Structural and functional disruption of vascular smooth muscle cells in a transgenic mouse model of amyloid angiopathy

Regional haemodynamic responses to the cannabinoid agonist, WIN 55212-2, in conscious, normotensive rats, and in hypertensive, transgenic rats

3-(1',1'-Dimethylbutyl)-1-deoxy-delta8-THC and related compounds: synthesis of selective ligands for the CB2 receptor

P304

422

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FNINS.2016.00422

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Dolores Prieto

María L de Ceballos

P577

2016-09-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27695396

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

cannabinoids

P932

5025475

http://www.w3.org/2001/XMLSchema#string